What Are CHO Cells and Why Are They Used for Protein Production?

Chinese Hamster Ovary (CHO) cells have become a cornerstone in the field of biotechnology, particularly for the production of therapeutic proteins. These cells, derived from a small rodent, have been adapted to thrive in laboratory conditions, making them ideal for large-scale protein production. But why are CHO cells so widely used, and what makes them so effective for this purpose?

CHO cells were first isolated in the 1950s and have since undergone extensive genetic manipulation to enhance their utility in research and industry. One of the primary reasons for their widespread use is their versatility. CHO cells can be easily cultivated in suspension cultures, which is crucial for scaling up the production process. This adaptability allows for efficient growth in bioreactors, which are necessary for producing the large quantities of protein required for therapeutic use.

Another significant advantage of CHO cells is their ability to perform post-translational modifications, such as glycosylation, which are critical for the activity and stability of many proteins. Human proteins produced in CHO cells typically have glycosylation patterns that closely resemble those found in natural human proteins. This similarity is crucial for reducing the risk of immune reactions when these proteins are used as therapeutics in humans.

CHO cells are also highly amenable to genetic engineering. Scientists have developed a variety of techniques to insert, delete, or modify genes within these cells, allowing for the production of a wide array of proteins. This genetic flexibility has led to the development of numerous CHO cell lines, each optimized for the production of specific proteins. As a result, researchers can tailor the cells to meet the specific needs of different pharmaceutical applications.

The safety record of CHO cells is another factor that has contributed to their popularity. Because they are derived from a non-human species, CHO cells pose less risk of carrying human pathogens. This characteristic makes them a safer choice for producing proteins intended for human use, as it reduces the chances of contamination that could lead to adverse effects.

CHO cells have also been at the forefront of innovation in the field of bioprocessing. Advances in cell culture technology, media formulation, and bioreactor design have all contributed to increasing the efficiency and yield of protein production using CHO cells. These improvements have made it possible to produce complex proteins at a relatively low cost, which is essential for making biologic therapies more accessible to patients worldwide.

Despite their many advantages, the use of CHO cells is not without challenges. For instance, optimizing the production process for a specific protein can be time-consuming and requires a deep understanding of cell biology and bioprocess engineering. However, ongoing research and development are continually overcoming these challenges, paving the way for even greater efficiencies and capabilities in protein production.

In conclusion, CHO cells are a critical component of modern biotechnology, especially in the realm of therapeutic protein production. Their versatility, ability to perform human-like post-translational modifications, and safety profile make them an invaluable tool for the pharmaceutical industry. As technology continues to advance, the role of CHO cells is likely to expand even further, offering new opportunities for the development and production of innovative therapies to treat a wide range of diseases.

Curious to see how Eureka LS fits into your workflow? From reducing screening time to simplifying Markush drafting, our AI Agents are ready to deliver immediate value. Explore Eureka LS today and unlock powerful capabilities that help you innovate with confidence.